Literature DB >> 32345063

Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic.

Robert Goodnough1, Karla Canseco1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32345063     DOI： 10.1080/15563650.2020.1758327

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN： 1556-3650            Impact factor:   4.467


× No keyword cloud information.
  2 in total

Review 1.  H2S as a potential defense against COVID-19?

Authors:  Guangdong Yang
Journal:  Am J Physiol Cell Physiol       Date:  2020-06-09       Impact factor: 4.249

Review 2.  Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19.

Authors:  Asimina Dominari; Donald Hathaway Iii; Abdulhusein Kapasi; Trissa Paul; Sarabjot Singh Makkar; Valeria Castaneda; Sirisha Gara; Bishnu Mohan Singh; Kuchalambal Agadi; Maliha Butt; Varadha Retnakumar; Spandana Chittajallu; Rahima Taugir; Muhammad Khawar Sana; Manish Kc; Sarah Razzack; Niala Moallem; Alina Alvarez; Michael Talalaev
Journal:  World J Virol       Date:  2021-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.